Pro-Dex (PDEX) Competitors $46.47 +0.43 (+0.93%) Closing price 09/3/2025 04:00 PM EasternExtended Trading$46.44 -0.03 (-0.06%) As of 04:00 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock PDEX vs. AVNS, ZIMV, KIDS, TMCI, SMLR, CBLL, DCTH, SNWV, BFLY, and RXSTShould you be buying Pro-Dex stock or one of its competitors? The main competitors of Pro-Dex include Avanos Medical (AVNS), ZimVie (ZIMV), OrthoPediatrics (KIDS), Treace Medical Concepts (TMCI), Semler Scientific (SMLR), CeriBell (CBLL), Delcath Systems (DCTH), Sanuwave Health (SNWV), Butterfly Network (BFLY), and RxSight (RXST). These companies are all part of the "medical equipment" industry. Pro-Dex vs. Its Competitors Avanos Medical ZimVie OrthoPediatrics Treace Medical Concepts Semler Scientific CeriBell Delcath Systems Sanuwave Health Butterfly Network RxSight Pro-Dex (NASDAQ:PDEX) and Avanos Medical (NYSE:AVNS) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their media sentiment, profitability, earnings, valuation, institutional ownership, analyst recommendations, dividends and risk. Does the media prefer PDEX or AVNS? In the previous week, Avanos Medical had 7 more articles in the media than Pro-Dex. MarketBeat recorded 8 mentions for Avanos Medical and 1 mentions for Pro-Dex. Avanos Medical's average media sentiment score of 1.23 beat Pro-Dex's score of 0.34 indicating that Avanos Medical is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Pro-Dex 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Avanos Medical 6 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Do insiders & institutionals hold more shares of PDEX or AVNS? 15.3% of Pro-Dex shares are owned by institutional investors. Comparatively, 95.2% of Avanos Medical shares are owned by institutional investors. 47.5% of Pro-Dex shares are owned by company insiders. Comparatively, 2.6% of Avanos Medical shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term. Which has stronger valuation and earnings, PDEX or AVNS? Pro-Dex has higher earnings, but lower revenue than Avanos Medical. Avanos Medical is trading at a lower price-to-earnings ratio than Pro-Dex, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioPro-Dex$53.84M2.81$2.13M$2.8016.60Avanos Medical$687.80M0.83-$392.10M-$10.07-1.22 Do analysts prefer PDEX or AVNS? Pro-Dex currently has a consensus target price of $56.00, suggesting a potential upside of 20.51%. Given Pro-Dex's stronger consensus rating and higher probable upside, analysts clearly believe Pro-Dex is more favorable than Avanos Medical.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Pro-Dex 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00Avanos Medical 0 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00 Which has more risk & volatility, PDEX or AVNS? Pro-Dex has a beta of -0.04, meaning that its share price is 104% less volatile than the S&P 500. Comparatively, Avanos Medical has a beta of 1.12, meaning that its share price is 12% more volatile than the S&P 500. Is PDEX or AVNS more profitable? Pro-Dex has a net margin of 14.61% compared to Avanos Medical's net margin of -66.89%. Pro-Dex's return on equity of 29.08% beat Avanos Medical's return on equity.Company Net Margins Return on Equity Return on Assets Pro-Dex14.61% 29.08% 16.19% Avanos Medical -66.89%6.16%4.57% SummaryPro-Dex beats Avanos Medical on 11 of the 16 factors compared between the two stocks. Get Pro-Dex News Delivered to You Automatically Sign up to receive the latest news and ratings for PDEX and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding PDEX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart PDEX vs. The Competition Export to ExcelMetricPro-DexMED/DENTAL IndustryMedical SectorNASDAQ ExchangeMarket Cap$152.88M$17.09B$5.77B$9.73BDividend YieldN/A1.48%6.66%4.49%P/E Ratio16.6017.7482.4626.60Price / Sales2.812.53505.10159.03Price / Cash48.9616.8925.7028.92Price / Book5.153.7210.966.56Net Income$2.13M$472.13M$3.28B$266.04M7 Day Performance0.04%-0.36%0.14%-0.89%1 Month Performance1.66%2.35%8.97%4.34%1 Year Performance110.27%5.84%52.36%24.06% Pro-Dex Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)PDEXPro-Dex2.3263 of 5 stars$46.47+0.9%$56.00+20.5%+108.1%$152.88M$53.84M16.60140AVNSAvanos Medical2.6469 of 5 stars$11.58-1.2%N/A-48.7%$543.37M$687.80M-1.152,227Positive NewsZIMVZimVie0.735 of 5 stars$18.96+0.1%$17.75-6.4%+9.6%$534.41M$449.75M-27.091,770News CoveragePositive NewsKIDSOrthoPediatrics4.3364 of 5 stars$20.29+0.4%$34.14+68.3%-31.5%$506.49M$204.73M-11.34200Positive NewsTMCITreace Medical Concepts2.5608 of 5 stars$7.47-3.0%$9.83+31.6%+26.7%$486.43M$209.36M-9.46250Positive NewsSMLRSemler Scientific3.4535 of 5 stars$30.02-4.5%$81.75+172.3%+17.8%$465.32M$42.98M12.35120Trending NewsCBLLCeriBell2.5707 of 5 stars$11.44-5.1%$32.14+181.0%N/A$442.17M$65.44M-3.83N/ADCTHDelcath Systems3.1618 of 5 stars$10.89-2.1%$24.50+125.0%+3.2%$388.99M$70.24M217.8060Positive NewsSNWVSanuwave Health2.6168 of 5 stars$42.66-5.2%$55.00+28.9%N/A$385.56M$32.63M-5.1740News CoverageAnalyst ForecastBFLYButterfly Network3.1951 of 5 stars$1.56+2.3%$3.00+92.9%+26.5%$382.65M$82.06M-5.55460Positive NewsRXSTRxSight2.3221 of 5 stars$8.61-7.2%$10.00+16.1%-83.3%$379.70M$139.93M-10.76220Trending News Related Companies and Tools Related Companies AVNS Competitors ZIMV Competitors KIDS Competitors TMCI Competitors SMLR Competitors CBLL Competitors DCTH Competitors SNWV Competitors BFLY Competitors RXST Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:PDEX) was last updated on 9/4/2025 by MarketBeat.com Staff From Our PartnersThe man running the U.S. dollar… is hoarding goldWhen the U.S. Treasury Secretary’s largest personal investment is gold — that’s a signal. Now a veteran gol...Golden Portfolio | SponsoredCrypto Income (almost instantly)How would you like to collect a small percentage of the $4 billion changing hands daily in the crypto market? ...Awesomely, LLC | SponsoredThe End of Elon Musk…?The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, an...Brownstone Research | SponsoredThis Massive Market is Ripe for Disruption by this NasdaqFanatics Hit $31B. This Nasdaq Company Is Building the Next Wave Fanatics built a merch empire by owning th...i2i Marketing Group, LLC | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | Sponsored“Shadow Group” in Washington, DC Could Crash MarketNew Amazon Crisis Could Tank U.S. Stock Market A new panic is halting AI projects at Amazon and could split...Altimetry | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored2013 Bitcoin miner reveals his trading system (free)While everyone else is gambling on meme coins or chasing the next "100x moonshot," our members are systematica...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Pro-Dex, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Pro-Dex With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free PDEX Stock Alerts